| HOME >> BIOLOGY >> TECHNOLOGY |
________ _______ ________ ________
Operating (loss)/income (67.3) (1,775.1) 95.7 (1,633.9)
Interest income 6.5 14.9 19.2 34.7
Interest expense (16.8) (28.0) (34.1) (35.8)
Other income/(expenses), net 0.7 1.8 13.4 2.3
________ _______ ________ ________
Total other (expenses)/income, net (9.6) (11.3) (1.5) 1.2
________ _______ ________ ________
(Loss)/income before income taxes
and equity in (losses)/earnings of
equity method investees (76.9) (1,786.4) 94.2 (1,632.7)
Income taxes (0.2) (25.6) (44.3) (67.1)
Equity in (losses)/earnings of
equity method investees (1.9) 0.7 (0.3) 1.2
________ _______ ________ ________
Net (loss)/income (79.0) (1,811.3) 49.6 (1,698.6)
________ _______ ________ ________
(1) For the three months to June 30, 2007 $4.7 million of depreciation
was reclassified from Selling, general and administrative (SG&A)
costs to Cost of product sales ($1.9 million) and Research and
Development costs ($2.8 million). For the six months to June 30, 2007
$8.7 million of depreciation was reclassified from SG&A costs to Cost
of product sales ($3.9 million) and Research and development ($4.8
million).
(2 ) Cost of product sales includes amortization of intangible assets
relating to favorable manufacturing contracts of $0.4 million for
the three months to June 30, 2008 (2007: $nil) and $0.9 million for
the six
'/>"/>
| SOURCE Shire Ltd Copyright©2008 PR Newswire. All rights reserved |